Adjusting weight to reflect group differences in Model [General Sta­tis­tics]

posted by ElMaestro  – Denmark, 2022-03-30 11:19 (47 d 10:11 ago) – Posting: # 22887
Views: 317

Hi all,

may I add that while adjustment for BW seems a nogo in 'ordinary' BE discplines, it is quite the opposite for biosimilars where you more often than not (said solely on basis of the biosimilars I am working on) add BW as a covariate in the model. I don't think it was entirely clear what type of product was behind the question in this case.

At any rate, regardless of whether BW is taken into account one way or another, all this should be established at the time of protocol drafting. If the idea to adjust by BW was a result of a failing BE study then, naturally, the prospects may not be good.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,074 posts in 4,629 threads, 1,565 registered users;
online 11 (0 registered, 11 guests [including 7 identified bots]).
Forum time: Monday 21:30 CEST (Europe/Vienna)

Rules are for the guidance of wise men
and the blind obedience of fools.    attributed to Solon

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5